18F-AlF-NOTA-neurotensin

N/A

Report date: 2025/11/20 11:38:02

NME

Base Information

Drug Name18F-AlF-NOTA-neurotensin

Drug Alias Name[18F]aluminum fluoride-1,4,7-triazacyclononane-1,4,7-triacetic acid-neurotensin

ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaPending

Originator CompaniesXiangya Hospital Of Central South University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesXiangya Hospital Of Central South University

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A